Line of Environmental Measurement Products
UPLC Separation Intergrates into Mass Spectrometers
Control Strategies for Synthetic Therapeutic Peptide APIs Part II: Raw Material Considerations
USP evaluates raw materials used in the chemical synthesis of peptides.
FDA and Manufacturers Seek a More Secure Drug Supply Chain
New identifiers and tracking requirements aim to block illegitimate products.
High-Performance Separation-Electrospray Ionization System
Biotech IPOs on a Hot Streak
Life-sciences companies continue upward momentum in 2014.
Global Instability Affects the Pharma Market in Brazil
How badly is Brazil's pharmaceutical market suffering from the global instability of emerging markets?
Raw Material Variability
The biopharmaceutical industry is developing a new approach to controlling variability in raw materials.
Monoclonal Antibodies Key to Unlocking the Biosimilars Market
The approval and acceptance of monoclonal antibody biosimilars is necessary if the biosimilars market is to experience real growth.
Publishing Beyond the Printed Page
More media options open publishing opportunities for bioprocessing experts and authors.
Biopharma Outsourcing Activities Update
Outsourcing activity remains strong and unlikely to abate, especially in more traditional areas.
Mass Spectrometer Enhances Performance in Protein Analysis
Liquid Chromatography Column Separates Glycans
Aggregation System Improves Analysis of Sub-Visible Particles
Implications of Trace Levels of Redox-Active Metals in Drug-Product Formulation
The presence of minute amounts of chelators can help minimize the degradation of monoclonal antibodies.
Quality by Design—Bridging the Gap between Concept and Implementation
As Europe strives to firmly incorporate quality-by-design principles, there are several key issues that still need to be addressed.
BioPharm International, April 2014 Issue (PDF)
Click the title above to open the BioPharm International April 2014 issue in an interactive PDF format.
